Legal status · United States
Is TERN-601 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. TERN-601 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
TERN-601 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Development discontinued after liver safety findings in the phase 2 study. Not available. |
| FDA approval status | Never approved. Clinical development was discontinued following liver safety findings in phase 2. |
| Human studies cited | 2 of 2 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the TERN-601 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing TERN-601 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What TERN-601 is
Dose-dependent weight loss in phase 1 and phase 2, then discontinued after three participants developed liver enzyme elevations consistent with potential drug-induced liver injury.
The second oral small-molecule GLP-1 agonist in this batch to work and be stopped, and its report is unusually clear about why. Phase 1 ran 28 days and produced dose-dependent weight loss with statistically significant reductions against placebo at every dose, along with the pharmacodynamic signatures you would expect from this class: reduced appetite and delayed gastric emptying.
Mechanism: An orally administered small-molecule agonist at the GLP-1 receptor, dosed once daily. Small molecules bind the receptor differently from the native peptide because they cannot reproduce its large binding surface, but the downstream signalling is the same: glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying and reduced appetite.
Regulatory history: Never approved. Clinical development was discontinued following liver safety findings in phase 2.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for TERN-601 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
TERN-601 in other countries
Frequently asked questions
Is TERN-601 legal in the United States?
No. TERN-601 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile. Note: Development discontinued after liver safety findings in the phase 2 study. Not available.
Can I buy TERN-601 in the United States?
No approved product exists to buy. In the United States TERN-601 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Development discontinued after liver safety findings in the phase 2 study. Not available.
Is TERN-601 FDA approved?
No. FDA status: Never approved. Clinical development was discontinued following liver safety findings in phase 2.. Current US classification: "Not approved; research use only". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for TERN-601 live on its compound profile.
TERN-601 profileThis page is general information about the regulatory status of TERN-601 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.